An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)
Clinical trial NCT05959070 · COMPLETED
Trial details
- NCT number
- NCT05959070
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-09
- Primary completion
- 2025-03-21
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.